Venkat Vuppala
About Venkat Vuppala
Venkat Vuppala is a Quality Control Specialist at Alkermes in Athlone, Ireland, with experience in both the Indian and Irish pharmaceutical industries.
Current Role at Alkermes
Venkat Vuppala currently holds the position of Quality Control Specialist at Alkermes, located in Athlone, County Roscommon, Ireland. In this role, Venkat is responsible for ensuring the quality and compliance of pharmaceutical products. His day-to-day duties likely involve rigorous testing and validation processes to meet industry standards and regulatory requirements. His experience in quality control is crucial to the company’s commitment to producing safe and effective medications.
Previous Role at Currys PC World Business
Before joining Alkermes, Venkat Vuppala worked as a Sales Associate at Currys PC World Business in Naas, County Kildare, Ireland, from 2019 to 2022. During his three-year tenure, he gained valuable experience in customer service and sales. His responsibilities included assisting customers, managing sales transactions, and contributing to store revenue. This role helped Venkat develop strong communication and interpersonal skills, which are beneficial in his current role.
Experience at Natco Pharma Limited
Venkat Vuppala has significant experience working with Natco Pharma Limited in Hyderabad, Telangana, India. He started as an Industrial Trainee from 2015 to 2016, where he spent 11 months learning the basics of the pharmaceutical industry. He then advanced to the role of Quality Control Analyst from 2016 to 2018. In this position, Venkat was involved in the meticulous processes of quality control, ensuring that pharmaceutical products met strict regulatory standards before reaching consumers.
Educational Background in Pharmaceutical Sciences
Venkat Vuppala studied at Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, where he earned a Bachelor’s degree in Pharmacy from 2012 to 2016. He furthered his education at the Institute of Technology, Carlow, obtaining a Master’s degree in Pharmaceutical Regulatory Affairs from 2019 to 2020. His Master’s program, which he completed in just one year, provided him with in-depth knowledge of regulatory requirements and compliance in the pharmaceutical industry.